Beijing Leadman Biochemistry Co Ltd (300289) — Financial Flexibility Index
Beijing Leadman Biochemistry Co Ltd (300289) has a Financial Flexibility Index of 0.14x as of September 2025. Free cash flow of CN¥13.28 Million (operating CF CN¥11.89 Million minus capex CN¥1.40 Million) represents 0% of total liabilities (CN¥96.51 Million). Check 300289 capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Beijing Leadman Biochemistry Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Beijing Leadman Biochemistry Co Ltd across 18 annual periods. See working capital to net assets of Beijing Leadman Biochemistry Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Beijing Leadman Biochemistry Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Beijing Leadman Biochemistry Co Ltd. For the full company profile including market capitalisation, see Beijing Leadman Biochemistry Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.44x | CN¥46.75 Million | CN¥29.16 Million | CN¥105.46 Million | ▼ -49.8% |
| 2024 | 0.88x | CN¥91.63 Million | CN¥62.41 Million | CN¥103.84 Million | ▼ -22.9% |
| 2023 | 1.14x | CN¥153.11 Million | CN¥134.42 Million | CN¥133.77 Million | ▲ +67.5% |
| 2022 | 0.68x | CN¥148.05 Million | CN¥108.93 Million | CN¥216.67 Million | ▲ +54.7% |
| 2021 | 0.44x | CN¥163.56 Million | CN¥119.06 Million | CN¥370.30 Million | ▼ -32.7% |
| 2020 | 0.66x | CN¥163.95 Million | CN¥135.56 Million | CN¥249.92 Million | ▲ +14.8% |
| 2019 | 0.57x | CN¥150.93 Million | CN¥124.65 Million | CN¥264.18 Million | ▲ +78.7% |
| 2018 | 0.32x | CN¥93.26 Million | CN¥81.02 Million | CN¥291.80 Million | ▼ -20.3% |
| 2017 | 0.40x | CN¥131.87 Million | CN¥120.97 Million | CN¥328.73 Million | ▲ +24.5% |
| 2016 | 0.32x | CN¥105.09 Million | CN¥81.78 Million | CN¥326.13 Million | ▼ -36.6% |
| 2015 | 0.51x | CN¥202.54 Million | CN¥177.82 Million | CN¥398.76 Million | ▲ +4364.0% |
| 2014 | 0.01x | CN¥5.96 Million | CN¥-13.21 Million | CN¥523.48 Million | ▼ -98.2% |
| 2013 | 0.62x | CN¥243.79 Million | CN¥90.45 Million | CN¥392.86 Million | ▼ -23.6% |
| 2012 | 0.81x | CN¥300.02 Million | CN¥57.86 Million | CN¥369.17 Million | ▼ -17.6% |
| 2011 | 0.99x | CN¥142.84 Million | CN¥29.34 Million | CN¥144.89 Million | ▲ +6.0% |
| 2010 | 0.93x | CN¥92.09 Million | CN¥53.46 Million | CN¥98.99 Million | ▼ -4.3% |
| 2009 | 0.97x | CN¥46.33 Million | CN¥31.26 Million | CN¥47.68 Million | ▲ +4.0% |
| 2008 | 0.93x | CN¥28.02 Million | CN¥21.98 Million | CN¥30.01 Million | — |